In 2010, Cannabidiol (CBD) Induces Programmed Cell Death in Glioblastoma Cells.
BACKGROUND: This study explored the effects of cannabidiol (CBD) on glioblastoma, a highly aggressive brain cancer.
Researchers examined how CBD influences programmed cell death (apoptosis) in glioblastoma cells. The goal was to understand its potential as a therapeutic agent.
METHODS AND RESULTS:
The study found that CBD triggered apoptosis in glioblastoma cells and inhibited their growth. These results highlight CBD’s potential as a treatment option for glioblastoma, either alone or in combination with other therapies.
In 2010, Study to find novel therapies for aggressive and non-responding or relapsing patients. With MMTV-neu mouse & 87 human breast tumors
Background: analyzed antitumor potential in a well established and clinically relevant model of ErbB2-driven metastatic breast cancer.
You can read the full story here => https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-9-196https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-9-196